This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 14 - 17, 2025
Marriott Marquis San DiegoLive In-Person Event: December 14 - 17, 2025

Kendra Avery, PhD
Director, Protein Sciences & Technology at Xencor
Speaker

Profile

Kendra Avery, Ph.D., is the Director of Protein Sciences and Technology at Xencor, where she leads efforts in antibody and protein therapeutic characterization. She holds a Ph.D. in Chemistry from Penn State and has a background in structural biology, protein engineering, and drug discovery.

Agenda Sessions

  • Engineering IBD Therapeutics: Novel High-Affinity mAbs with Extended Half-Life Targeting TL1A and Il-23p19”

    3:30pm